Jazz Pharma Plc (JAZZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 287,628 | 138,312 | 45,991 | 487,848 | 255,641 |
| Depreciation Amortization | 198,987 | 136,927 | 14,339 | 195,180 | 127,686 |
| Income taxes - deferred | -44,658 | -32,228 | -15,307 | -225,591 | -53,359 |
| Accounts receivable | -55,518 | -54,356 | -56,591 | 12,278 | -22,273 |
| Accounts payable and accrued liabilities | 10,116 | 7,371 | 23,136 | 214 | 6,130 |
| Other Working Capital | 6,456 | 7,605 | 28,154 | 26,766 | -14,684 |
| Other Operating Activity | 177,797 | 155,702 | 127,637 | 196,392 | 189,387 |
| Operating Cash Flow | $580,808 | $359,333 | $167,359 | $693,087 | $488,528 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -356,250 | -120,350 | -45,000 | -155,000 | -140,000 |
| PPE Investments | 32,871 | -11,281 | -7,149 | -28,950 | -20,072 |
| Purchase Sale Intangibles | -111,100 | -111,102 | N/A | -85,000 | -77,000 |
| Other Investing Activity | -111,100 | -111,102 | 0 | -85,000 | -77,000 |
| Investing Cash Flow | $-434,479 | $-242,733 | $-52,149 | $-268,950 | $-237,072 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 559,393 | 559,484 |
| Debt Repayment | -17,370 | -9,023 | -9,023 | -886,094 | -877,070 |
| Common Stock Issued | 84,056 | 67,058 | 10,588 | 31,824 | 22,793 |
| Common Stock Repurchased | -77,015 | -55,561 | -34,546 | -98,799 | -56,425 |
| Other Financing Activity | -22,345 | -21,176 | -14,594 | -15,435 | -17,909 |
| Financing Cash Flow | $-32,674 | $-18,702 | $-47,575 | $-409,111 | $-369,127 |
| Exchange Rate Effect | -672 | 1,148 | -501 | 5,046 | 4,323 |
| Beginning Cash Position | 386,035 | 386,035 | 386,035 | 365,963 | 365,963 |
| End Cash Position | 499,018 | 485,081 | 453,169 | 386,035 | 252,615 |
| Net Cash Flow | $112,983 | $99,046 | $67,134 | $20,072 | $-113,348 |
| Free Cash Flow | |||||
| Operating Cash Flow | 580,808 | 359,333 | 167,359 | 693,087 | 488,528 |
| Capital Expenditure | -15,221 | -11,281 | -7,149 | -28,950 | -20,072 |
| Free Cash Flow | 565,587 | 348,052 | 160,210 | 664,137 | 468,456 |